A detailed history of Murphy Pohlad Asset Management LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Murphy Pohlad Asset Management LLC holds 2,000 shares of MRNA stock, worth $120,400. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,000
Previous 2,000 -0.0%
Holding current value
$120,400
Previous $213,000 11.27%
% of portfolio
0.1%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$85.37 - $115.44 $4,268 - $5,772
-50 Reduced 2.44%
2,000 $213,000
Q4 2023

Jan 19, 2024

BUY
$69.51 - $104.43 $3,475 - $5,221
50 Added 2.5%
2,050 $203,000
Q3 2023

Oct 10, 2023

SELL
$96.41 - $126.61 $20,728 - $27,221
-215 Reduced 9.71%
2,000 $206,000
Q3 2022

Oct 24, 2022

BUY
$118.07 - $194.18 $261,525 - $430,108
2,215 New
2,215 $261,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $23.6B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Murphy Pohlad Asset Management LLC Portfolio

Follow Murphy Pohlad Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Murphy Pohlad Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Murphy Pohlad Asset Management LLC with notifications on news.